Biochemical and pharmacological characterization of FR134043, a novel elastase inhibitor

被引:13
|
作者
Shinguh, Y [1 ]
Yamazaki, A [1 ]
Inamura, N [1 ]
Fujie, K [1 ]
Okamoto, M [1 ]
Nakahara, K [1 ]
Notsu, Y [1 ]
Okuhara, M [1 ]
Ono, T [1 ]
机构
[1] Fujisawa Pharmaceut Co Ltd, Exploratory Res Labs, Tsukuba, Ibaraki 30026, Japan
关键词
FR134043; elastase inhibitor; elastase; adult respiratory distress syndrome; disseminated intravascular coagulation; septic shock; pulmonary emphysema; hemorrhage; edema;
D O I
10.1016/S0014-2999(98)00028-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
FR 134043, disodium(Z1S,15S,18S,24S,27R,29S,34S,37R)-29-benzyl-21-ethylidene-27-hydroxy-15-isobutyrylamino-34-isopropyl-31,37-dimethyl-10,16,19,22,30,32,35,38-octaoxo-36-oxa-9,11,17,20,23,28,31,33-octaazatetracyclo[16.13.61(24, 28).0(3, 8)]octatriconta-3,5,7-trien-5,6-diyl disulfate, is a water-soluble inhibitor of human neutrophil elastase with a molecular mass of 1166.15 Da. FR134043 demonstrated a characteristic competitive inhibition of human neutrophil elastase with a K-i of 8 nM. In studies using synthetic substrates, FR134043 inhibited both neutrophil elastase activity and porcine pancreatic elastase activity with IC50 values of 35 nM and 49 nM respectively. FR134043 also inhibited hydrolysis of bovine neck ligament elastin by human neutrophil elastase with an IC50 value of 210 nM. In in vivo experiments, FR134043 protected animals against human neutrophil elastase (50 mu g/animal)-induced lung hemorrhage in hamsters with an ED50 value of 3.1 mu g/animal for intratracheal administration and 5.0 mg/kg for intravenous administration. Subcutaneous treatment with FR134043 significantly suppressed human neutrophil elastase (20 mu g/paw)-induced paw edema in mice with an ED50 value of 3.3 mg/kg when evaluated 4 h after elastase injection. The potency of FR134043 given intratracheally to protect against porcine pancreatic elastase (100 mu g/animal)-induced emphysema in hamsters was relatively low (Quasi-static lung compliance; ED50 = 1590 mu g/animal) compared to that in acute animal models. FR134043 (10 mg/kg per h i.v. infusion) significantly improved lipopolysaccharide (0.25 mg/kg per h i.v. infusion)-induced thrombocytopenia and some coagulation parameters in rats. These results suggest that systemic administration of FR134043 would be advantageous over intratracheal administration of FR134043 for the treatment of adult respiratory distress syndrome, septic shock and pulmonary emphysema and other pathophysiologic conditions in which elastases are thought to be involved. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:299 / 308
页数:10
相关论文
共 50 条
  • [21] MOLECULAR CHARACTERIZATION OF MONOCYTE NEUTROPHIL EI, A NOVEL HUMAN ELASTASE INHIBITOR
    REMOLDODONNELL, E
    CHIN, J
    ALBERTS, M
    FASEB JOURNAL, 1992, 6 (05): : A1974 - A1974
  • [22] PHARMACOLOGICAL AND BIOCHEMICAL ASSESSMENT OF SM-10888, A NOVEL CHOLINESTERASE INHIBITOR
    NATORI, K
    OKAZAKI, Y
    IRIE, T
    KATSUBE, J
    JAPANESE JOURNAL OF PHARMACOLOGY, 1990, 53 (02): : 145 - 155
  • [23] ELASTASE INHIBITOR - CHARACTERIZATION OF THE HUMAN ELASTASE INHIBITOR MOLECULE ASSOCIATED WITH MONOCYTES, MACROPHAGES, AND NEUTROPHILS
    REMOLDODONNELL, E
    NIXON, JC
    ROSE, RM
    JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (03): : 1071 - 1086
  • [24] Active Structure of FR901451, a Potent Macrocyclic Elastase Inhibitor
    Kinoshita, Takayoshi
    Kitatani, Tomoya
    Tada, Toshiji
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C244 - C244
  • [25] STRUCTURE OF ELASNIN, A NOVEL ELASTASE INHIBITOR
    OMURA, S
    NAKAGAWA, A
    OHNO, H
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1979, 101 (15) : 4386 - 4388
  • [26] Molecular structure of FR901277, a novel inhibitor of human leukocyte elastase, and its binding mode simulation
    Nakanishi, I
    Kinoshita, T
    Tada, T
    Fujita, T
    Hatanaka, H
    Sato, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (16) : 2397 - 2402
  • [27] Structure of porcine pancreatic elastase complexed with FR901277, a novel macrocyclic inhibitor of elastases, at 1.6 Å resolution
    Nakanishi, I
    Kinoshita, T
    Sato, A
    Tada, T
    BIOPOLYMERS, 2000, 53 (05) : 434 - 445
  • [28] PURIFICATION AND CHARACTERIZATION OF A NOVEL ELASTASE INHIBITOR FROM THE LEECH HIRUDINARIA-MANILLENSIS
    ELECTRICWALA, A
    SAWYER, RT
    VONSICARD, N
    IRONS, L
    ATKINSON, T
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1210 - 1210
  • [29] Pharmacological characterization of AX-9657, a potent and selective neutrophil elastase inhibitor with good lung distribution
    Ishiyama, Junichi
    Araki, Kenji
    Miura, Masahiro
    Kitamura, Yoshiaki
    Izawa, Shigeru
    Okerberg, Eric S.
    Lin, Emme C. K.
    Shreder, Kevin R.
    Murakami, Koji
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [30] THE ISOLATION AND CHARACTERIZATION OF A NEW ELASTASE INHIBITOR, PRE-ALPHA-2-ELASTASE INHIBITOR, OF THE HORSE
    PELLEGRINI, A
    VONFELLENBERG, R
    BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 797 (03) : 336 - 342